| Identification | Back Directory | [Name]
2-Dodecanol, 1,1',1'',1'''-[1,4-piperazinediylbis(2,1-ethanediylnitrilo)]tetrakis- | [CAS]
1265904-26-4 | [Synonyms]
2-Dodecanol, 1,1',1'',1'''-[1,4-piperazinediylbis(2,1-ethanediylnitrilo)]tetrakis- | [Molecular Formula]
C56H116N4O4 | [MOL File]
1265904-26-4.mol | [Molecular Weight]
909.54 |
| Chemical Properties | Back Directory | [Boiling point ]
887.9±65.0 °C(Predicted) | [density ]
0.945±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 25 mg/mL (27.49 mM; Need ultrasonic) | [form ]
Solid | [pka]
14.15±0.20(Predicted) | [color ]
Light yellow to orange |
| Hazard Information | Back Directory | [Uses]
1,1′,1′′,1′′′-[1,4-Piperazinediylbis(2,1-ethanediylnitrilo)]tetrakis[2-dodecanol] is a lipid/lipidoid used in preparation of lipid-based or lipidoid nanoparticles[1]. | [Biological Activity]
1,1′,1′′,1′′′-[1,4-Piperazinediylbis(2,1-ethanediylnitrilo)]tetrakis[2-dodecanol] is a lipid/lipidoid used in preparation of lipid-based or lipidoid nanoparticles[1]. | [storage]
Store at -20°C | [References]
[1]. Miller AD. Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices. 2013;10(6):781-811. |
|
|